Featured Research

from universities, journals, and other organizations

Gene Therapy Restores Vision Cells In Blind Mice

Date:
May 21, 2007
Source:
University of Florida
Summary:
Researchers used gene therapy to restore sight in mice with a form of hereditary blindness, a finding that has bearing on many of the most common blinding diseases. They describe how they used a harmless virus to deliver corrective genes to mice with a genetic impairment that robs them of vision.

UF scientists William W. Hauswirth (left) and John J. Alexander show in mice that it is possible to use gene therapy to target and rescue cone cells - the most important cells for visual sharpness and color vision in people. Scientists experimented with mice with a form of hereditary blindness called achromatopsia, which affects about 1 in 30,000 Americans by disabling cone photoreceptors in the retina.
Credit: Sarah Kiewel/UF Health Science Center

University of Florida researchers used gene therapy to restore sight in mice with a form of hereditary blindness, a finding that has bearing on many of the most common blinding diseases.

In the May 21 edition of Nature Medicine (online) scientists describe how they used a harmless virus to deliver corrective genes to mice with a genetic impairment that robs them of vision.

The discovery shows that it is possible to target and rescue cone cells -- the most important cells for visual sharpness and color vision in people.

"Cone vision defines whether someone is blind or not," said William W. Hauswirth, Ph.D., the Rybaczki-Bullard professor of ophthalmic molecular genetics in the College of Medicine and a member of the UF Genetics Institute. "If you can usefully deliver a gene specifically to cone cells, there are implications for all blinding diseases, not just inherited ones. Even in two very common types of blindness, age-related macular degeneration and diabetic retinopathy, if you can target cones you might be able to rescue that vision."

Scientists experimented with mice with a form of hereditary blindness called achromatopsia, which affects about 1 in 30,000 Americans by disabling cone photoreceptors in the retina. The disease results in nearly complete color blindness and extremely poor central vision.

Within two months of the gene therapy injection into the subretinal space of the mouse eyes, scientists measured the electrical activity in the retinas, finding that 19 of the 21 treated eyes positively responded to therapy, and 17 of those 19 had electrical readings from their retinas on par with those taken in normal mice.

When the mice were between 6 and 7 months old, tests showed 18 of the 21 treated eyes continued to respond normally.

In addition, a separate, smaller group of treated mice were evaluated using an exam akin to an eye test at the doctor's office.

In experiments overseen by Robert B. Barlow, Ph.D., a professor of ophthalmology at State University of New York Upstate Medical University, the mice were surrounded by four computer monitors that simulated the appearance of being inside a moving drum that had vertical stripes on the walls.

Scientists knew the mice could see the stripes because sighted animals naturally move their heads in the same direction as the moving stripes. By making the stripes ever-narrower -- similar to how the letters get smaller toward the bottom of an eye chart -- researchers could assess the mice's visual abilities.

As a group, all of the mice displayed normal visual acuity in their treated eyes.

"People can talk and tell us what they see," said lead researcher John J. Alexander, Ph.D., a postdoctoral fellow in the department of ophthalmology at UF. "Animals are much more difficult. What makes this test so fantastic is that it involves an animal's natural response, and the results tell us that the animals' brains are involved in the process, that they are actually seeing something."

In addition to cones, which number about 6 million in the retina, the eye's rod cells are important for low-light and peripheral vision and exist in much greater amounts, with populations of more 100 million.

But treating cones could play a role in diseases that begin with the destruction of rods, such as retinitis pigmentosa, which affects about 1 in 3,000 Americans.

"This is the first to my knowledge of a cone-targeted gene therapy that restores function in an animal model where cones are the primary defect," said Richard Weleber, Ph.D., a professor of molecular and medical genetics at Oregon Health & Science University who was not involved in the research. "This validates the concept that it is possible to deliver a gene therapy targeting the cone system, and that is incredibly important for a number of degenerative diseases."

The research was supported by grants from the National Institutes for Health, the Foundation for Fighting Blindness, the Juvenile Diabetes Research Foundation, the Macula Vision Research Foundation, the Lions of Central New York, Research to Prevent Blindness, Fight for Sight and NASA.

UF and Hauswirth have an interest in a biotechnology company that may seek to market some of the research technology.


Story Source:

The above story is based on materials provided by University of Florida. Note: Materials may be edited for content and length.


Cite This Page:

University of Florida. "Gene Therapy Restores Vision Cells In Blind Mice." ScienceDaily. ScienceDaily, 21 May 2007. <www.sciencedaily.com/releases/2007/05/070521134733.htm>.
University of Florida. (2007, May 21). Gene Therapy Restores Vision Cells In Blind Mice. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2007/05/070521134733.htm
University of Florida. "Gene Therapy Restores Vision Cells In Blind Mice." ScienceDaily. www.sciencedaily.com/releases/2007/05/070521134733.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins